MegaRobo Technologies

MegaRobo is an artificial intelligence & robotics company empowering biotech innovation breakthroughs.

MegaRobo focuses on the research and development of collaborative robots and the supporting artificial intelligence technologies, provides flexible and practical automation solutions for life sciences, intelligent retail and lightweight manufacturing.

MegaRobo Technologies was founded in 2016 by Daniel Huang. The company is headquartered in Beijing, with branches in Shenzhen, Shanghai, and Suzhou.

 

MegaRobo's workflow automation integrates different processes and applications by combining AI software, analytical instruments, hardware and consumables into one system.

 

MegaRobo has collaborated with leading life sciences companies to build the infrastructure and platform to optimize R&D process and improve efficiency. In organoids, MegaRobo has partnered with CELLada to achieve high-throughput large-scale cultivation and testing.

 

MegaRobo has a number of core technologies that are competitive in the world and has applied for over 200 invention patents, which have passed the IOS9001 Quality Management System Certification.

 

MegaRobo is backed by Goldman Sachs Asset Management, Sinovation Ventures, Asia Investment Capital, GGV Capital, Pavilion Capital, Starr Capital, U-Member Capital, and others. The company raised $300M in Series C round on Jun 15, 2022. This brings MegaRobo's total funding to $425.8M to date. Megarobo was valued at over $1B from its Series B round raised in Nov 2020.

 

 

  • Year founded: 2016
  • Funding Info: $425.8M over 5 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 501-1,000
  • Business Valuation: Valued at over $1B as of Nov 2020
  • City/Town: Beijing
  • State: Beijing
  • Country: China
Related businesses